|
|
 |
Mission
Statement:
The Cancer Education and Research Foundation of Texas is dedicated to the
promotion, support, and advancement of high quality cancer care. To achieve
this goal, the Foundation shall use its financial resources to promote and
encourage the continuing education of oncology health professionals, sponsor
and/or conduct oncology research projects, develop educational products for the
public, support and provide counseling for oncology patients and their families
and develop and support alternative medical treatments for oncology patients.
The Foundation shall attempt to educate the public about cancer and act as a
resource center for cancer education. It shall develop and support community
programs that provide early detection and screening and make the public aware of
the medical advancements in the treatment of cancer. The Foundation shall
develop and fund programs that assist cancer patients by providing
transportation and financial assistance for those who are unable to provide for
themselves.
Cancer
Education and Research Foundation of Texas Board of Directors:
Glenn Darden,
Chairman of Board
President and CEO Quicksilver Resources
Kelly Jones,
Vice Chairman
Attorney,
Jones and Cannon
Dr. Ray
Page, Medical Oncologist
Texas Cancer Care
Lynn Ranelle
Christopher Baker
Attorney - Pennington, Hill, and Baker
Executive Director: Truitt
Clinard
For more information about CERFT or to make a donation, please
call our office at 817 759-7018.
|
|
|
|
Background:
Established in
March 2000, the Cancer Education and Research Foundation (CERFT)
has provided treatment through clinical trials to nearly 400
cancer patients. At any given time, there are approximately 15
separate trials being offered to treat breast, lung, colorectal,
leukemia/lymphoma, prostate, pancreatic, and ovarian cancers.
CERFT is
currently exploring more opportunities to assist cancer patients
and their families through supporting community education
programs for prevention, detection, and treatment; financial and
emotional/psychological assistance; continuing education for
medical professionals; and a pioneering program to provide
research in the area of adolescent/young adult cancer.
|
|
